The effect of continuity of care on the incidence of end-stage renal disease in patients with newly detected type 2 diabetic nephropathy: a retrospective cohort study

被引:12
|
作者
Jang, Yun Jung [1 ,2 ]
Choy, Yoon Soo [3 ,4 ]
Nam, Chung Mo [5 ,6 ]
Moon, Ki Tae [7 ]
Park, Eun-Cheol [4 ,5 ,6 ]
机构
[1] Minist Hlth & Welf, Hlth Insurance Dispute Mediat Comm, Sejong Govt Complex, Sejong City, South Korea
[2] Yonsei Univ, Grad Sch Publ Hlth, Dept Hlth Policy & Management, Seoul, South Korea
[3] Yonsei Univ, Grad Sch, Dept Publ Hlth, Seoul, South Korea
[4] Yonsei Univ, Inst Hlth Serv Res, Seoul, South Korea
[5] Yonsei Univ, Coll Med, Dept Prevent Med, 50 Yonsei Ro, Seoul 120752, South Korea
[6] Yonsei Univ, Coll Med, Inst Hlth Serv Res, 50 Yonsei Ro, Seoul 120752, South Korea
[7] Natl Evidence Based Healthcare Collaborating Agcy, Seoul, South Korea
来源
BMC NEPHROLOGY | 2018年 / 19卷
关键词
Diabetic renal complication; Continuity of care; ESRD; Disparities in health outcomes; ELDERLY-PEOPLE; RISK-FACTORS; HEALTH-CARE; MELLITUS; OUTCOMES; COSTS; KOREA; HOSPITALIZATIONS; HYPERTENSION; MORTALITY;
D O I
10.1186/s12882-018-0932-3
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Diabetic nephropathy requires periodic monitoring, dietary modification, and early intervention to prevent the disease severity within limited resource settings. To emphasize the importance of continuous care for chronic diseases, various studies have focused on the association between continuity of care (COC) and common adverse outcomes. However, studies aimed at understanding the effect of COC on the incidence of chronic diseases, such as end-stage renal disease (ESRD), are few. The aim of this study was to determine whether there is an association between COC and the incidence of ESRD among patients with diabetic nephropathy. Moreover, we identified individual-and hospital-level factors associated with the incidence of ESRD among diabetic nephropathy patients. Methods: We conducted a retrospective cohort study using the administrative National Health Insurance claims data from 2005 to 2012 in the Republic of Korea. The dependent variable, a binary variable, was the incidence of ESRD due to diabetic renal complication. In addition, using the COC index as a binary variable with a cutoff point of 0.75, we divided patients into a 'Good COC group' (COC index >= 0.75) and a 'Bad COC group' (COC index<0.75). The survival analysis was performed using the Cox proportional hazards models. Results: Among 3565 diabetic renal complication patients, ESRD occurred among 83 diabetes mellitus patients (2.3%). Nephropathy patients with lower COC level (< 0.75) had 1.99 times higher risk of ESRD incidence (95% confidence interval [CI]: 1.27-3.12). In addition, the lowest income level patients had higher hazard ratio (HR) of ESRD than the highest income level patients (HR: 1.69 95% CI: 0.95-2.98), while patients with disabilities had 2.70 higher HR of ESRD than patients without disabilities (95% CI: 0.64-43). Conclusions: Among patients with diabetic renal complication, higher continuity of care was associated with lower risk of ESRD. It is therefore recommended that continuous follow-up be encouraged to prevent ESRD among diabetic renal complication patients. Moreover, disparities in health outcomes between socially vulnerable groups including patients with disabilities and those in the lowest income level should be addressed.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] The effect of continuity of care on the incidence of end-stage renal disease in patients with newly detected type 2 diabetic nephropathy: a retrospective cohort study
    Yun Jung Jang
    Yoon Soo Choy
    Chung Mo Nam
    Ki Tae Moon
    Eun-Cheol Park
    BMC Nephrology, 19
  • [2] Renal disease in relatives of Indo-Asian Type 2 diabetic patients with end-stage diabetic nephropathy
    Shaw, PKC
    van Es, LA
    Paul, LC
    Rosendaal, FR
    Souverijn, JHM
    Vandenbroucke, JP
    DIABETOLOGIA, 2003, 46 (05) : 618 - 624
  • [3] Renal disease in relatives of Indo-Asian Type 2 diabetic patients with end-stage diabetic nephropathy
    P. K. Chandie Shaw
    L. A. van Es
    L. C. Paul
    F. R. Rosendaal
    J. H. M. Souverijn
    J. P. Vandenbroucke
    Diabetologia, 2003, 46 : 618 - 624
  • [4] Hypomagnesemia in Type 2 Diabetic Nephropathy A novel predictor of end-stage renal disease
    Sakaguchi, Yusuke
    Shoji, Tatsuya
    Hayashi, Terumasa
    Suzuki, Akira
    Shimizu, Morihiro
    Mitsumoto, Kensuke
    Kawabata, Hiroaki
    Niihata, Kakuya
    Okada, Noriyuki
    Isaka, Yoshitaka
    Rakugi, Hiromi
    Tsubakihara, Yoshiharu
    DIABETES CARE, 2012, 35 (07) : 1591 - 1597
  • [5] Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy
    Mohanram, A
    Zhang, Z
    Shahinfar, S
    Keane, WF
    Brenner, BM
    Toto, RD
    KIDNEY INTERNATIONAL, 2004, 66 (03) : 1131 - 1138
  • [6] Continuity of care with physicians and risk of subsequent hospitalization and end-stage renal disease in newly diagnosed type 2 diabetes mellitus patients
    Chang, Po-Ya
    Chien, Li-Nien
    Bai, Chyi-Huey
    Lin, Yuh-Feng
    Chiou, Hung-Yi
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2018, 14 : 511 - 521
  • [7] Quality of Care in Chronic Kidney Disease and Incidence of End-stage Renal Disease in Older Patients A Cohort Study
    Fukuma, Shingo
    Ikenoue, Tatsuyoshi
    Shimizu, Sayaka
    Norton, Edward C.
    Saran, Rajiv
    Yanagita, Motoko
    Kato, Genta
    Nakayama, Takeo
    Fukuhara, Shunichi
    Funakoshi, T.
    Goto, Y.
    Goto, E.
    Hanaki, N.
    Hiragi, S.
    Iwao, T.
    Kawakami, K.
    Kondo, N.
    Kunisawa, S.
    Mori, Y.
    Nakatsui, M.
    Neff, Y.
    Ohtera, S.
    Okamoto, K.
    Otsubo, T.
    Saito, H.
    Saito, Y.
    Sakai, M.
    Sato, I
    Seto, K.
    Takahashi, Y.
    Yamashita, K.
    Yoshida, S.
    MEDICAL CARE, 2020, 58 (07) : 625 - 631
  • [8] The impact of losartan on the lifetime incidence of end-stage renal disease and costs in patients with type 2 diabetes and nephropathy
    Carides, George W.
    Shahinfar, Shahnaz
    Dasbach, Erik J.
    Keane, William F.
    Gerth, William C.
    Alexander, Charles M.
    Herman, William H.
    Brenner, Barry M.
    PHARMACOECONOMICS, 2006, 24 (06) : 549 - 558
  • [9] The Impact of Losartan on the Lifetime Incidence of End-Stage Renal Disease and Costs in Patients with Type 2 Diabetes and Nephropathy
    George W. Carides
    Shahnaz Shahinfar
    Erik J. Dasbach
    William F. Keane
    William C. Gerth
    Charles M. Alexander
    William H. Herman
    Barry M. Brenner
    PharmacoEconomics, 2006, 24 : 549 - 558
  • [10] Effect of periodontitis on overt nephropathy and end-stage renal disease in type 2 diabetes
    Shultis, Wendy A.
    Weil, E. Jennifer
    Looker, Helen C.
    Curtis, Jeffrey M.
    Shlossman, Marc
    Genco, Robert J.
    Knowler, William C.
    Nelson, Robert G.
    DIABETES CARE, 2007, 30 (02) : 306 - 311